Patent · US Active

Techniques and devices providing adaptivity and personalization in diabetes treatment

US11957875B2 · kind B2 · utility

0Cited by
289References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2020
Grant dateApr 16, 2024
Priority date
Expiry dateJan 20, 2043

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2230/201
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Disclosed are a device, system, methods and computer-readable medium products that provide an updated insulin-to-carbohydrate ratio and an updated total daily insulin. The described processes may be used for periodic updating of the insulin-to-carbohydrate ratio and the total daily insulin. The insulin-to-carbohydrate ratio and/or the total may be used in the calculation of new doses of insulin that a drug delivery device may be commanded to deliver to a user.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.